http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_53f877f5e74aac75168abbee35cfb272
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Piccart |
| name | Martine Piccart |
| given-name | Martine |
| organization-name | Institut Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium Institut Jules Bordet, Université Libre de Bruxelles From the Centre Oscar Lambret, Lille; Centre Georges-François Leclerc, Dijon; and Centre Eugène Marquis, Rennes, France; Karolinska Hospital, Stockholm; University Hospital, Uppsala, Sweden; Institute of Cancer Research, Sutton; Cancer Research United Kingdom Laboratories, Imperial College, London, United Kingdom; Institut Jules Bordet and European Organisation for Research and Treatment of Cancer Data Center, Brussels, Belgium; National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario... Medical Oncology Clinic, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium 1Jules Bordet Institute, Brussels, Belgium; Michail Ignatiadis, Sandeep K. Singhal, Christine Desmedt, Carmen Criscitiello, Sherene Loi, Martine Piccart, Stefan Michiels, and Christos Sotiriou, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Benjamin Haibe-Kains, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, MA; and Fabrice Andre, Institut Gustave Roussy, Université Paris XI, Paris, France. Internal Medicine/Oncology, Institut Jules Bordet, Brussels, Belgium. 12Jules Bordet Institute, Brussels, Belgium. From the Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Edinburgh Cancer Research UK Centre, University of Edinburgh, Edinburgh, United Kingdom; and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. 1Medical Oncology Department, Jules Bordet Institute; Breast International Group Headquarters (BIG-aisbl), Brussels 1000, Belgium;,; Institut Jules Bordet, Université Libre de Bruxelles, Brussels 1000, Belgium 5Department of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium. Institut Jules Bordet and L'Universite Libre de Bruxelles, Brussels, Belgium. Electronic address: martine.piccart@bordet.be. 1Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Boulevard de Waterloo 121, 1000, Brussels, Belgium. 7Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (ULB) , Brussels, Belgium 7Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Felipe Ades, Lina Pugliano, Debora Fumagalli, Evandro de Azambuja, Christos Sotiriou, and Martine Piccart, Institut Jules Bordet, Université Libre de Bruxelles; Dimitrios Zardavas, Breast International Group, Brussels, Belgium; Ivana Bozovic-Spasojevic, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia; and Giuseppe Viale, European Institute of Oncology, University of Milan, Milan, Italy. From the Division of Medical Oncology, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada; Division of Hematology and Medical Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL; Department of Medical Oncology, Institut Bergonié, Bordeaux; Department of Medical Oncology, CRLC Val d’ Aurelle-Paul Lamarque, Montpellier, France; Medical Oncology, Instituto National de Cancer, Rio de Janeiro; Departmento de Radiologia, Faculdade de... Institut Jules Bordet & l'Université Libre de Bruxelles, Brussels, Belgium Université Libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (HUB), Institut Jules Bordet, Brussels, Belgium 18Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Brussels, Belgium. Department of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles, Brussels, Belgium 1Translational Research Unit and Internal Medicine/Oncology, Institut Jules Bordet, Brussels, Belgium Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Breast Cancer Translational Research Laboratory J.-C. Heuson, Institut Jules Bordet, Universit� Libre de Bruxelles, 1000 Brussels, Belgium Jules Bordet Institute, Brussels, Belgium Affiliations of authors: Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria (MGn); Solid Tumor Breast Department, Memorial Sloan-Kettering Cancer Center, New York, NY (JB); Department of Medicine (Hematology/Oncology), University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA (HSR); Department of Sur Authors' Affiliation: Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium 10Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Jules Bordet Institute Université Libre de Bruxelles, Brussels, Belgium Chemotherapy Unit, Institut Jules Bordet, Brussels, Belgium 3Jules Bordet Institute, Brussels, Belgium; Oncology Department, Institut Jules Bordet, Brussels, Belgium Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium c Institut Jules Bordet, Bruxelles, Belgium ULB‐Cancer Research Center (U‐CRC) Université Libre de Bruxelles Brussels Belgium; Medical Oncology Clinic Department of Medicine Institut Jules Bordet Université Libre de Bruxelles (ULB) Brussels Belgium Jose Baselga, Memorial Sloan-Kettering Cancer Center, NY; James G. Greger Jr, GlaxoSmithKline, Collegeville, PA; Hatem A. Azim Jr, Martine Piccart, Evandro de Azambuja, BrEAST Data Centre, Institut Jules Bordet, Université Libre de Bruxelles; Phuong Dinh, Breast International Group, Brussels; Peter Vuylsteke, Sint-Elisabeth Hospital, Namur, Belgium; Dominique Agbor-tarh, Ian Bradbury, Frontier Science, Kincraig, Kingussie, Scotland; Ian Smith, Royal Marsden Hospital, and Institute of Cancer Research,... 4Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Bruxelles, Belgium. Department of Medical Oncology, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121, 1000 Bruxelles, Belgium 8Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Department of Medical Oncology Jules Bordet Institute Boulevard de Waterloo 121 Brussels Belgium Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; David Chen, Tetiana Taran, and David Lebwohl, Novartis Pharmaceuticals, East Hanover, NJ; Martine Piccart and Fabienne Lebrun, Université Libre de Bruxelles, Brussels; Ines Deleu, Oncology Centre, AZ Nikolaas, Sint-Nikolaas, Belgium; Hope S. Rugo, University of California, San Francisco; Ian Anderson, Redwood Regional Oncology Center, Santa Rosa, CA; Howard A. Burris, Sarah Cannon Research Institute, Nashville, TN;... From the University Health Network, Princess Margaret Hospital, Toronto; National Cancer Institute of Canada Clinical Trials Group, Queen's University Cancer Research Institute, Kingston, Ontario; QOL Consulting, Vancouver, British Columbia; Tom Baker Cancer Centre, Calgary, Alberta, Canada; Chinese University of Hong Kong, Hong Kong, China; and Institut Jules Bordet, Brussels, Belgium Unité de chimiothérapie, Institut Jules-Bordet, 1, rue Heger-Bordet, 1000 Bruxelles, Belgique. Authors' Affiliations: 1Breast Cancer Translational Research Laboratory JC Heuson, 2Laboratory of Oncology and Experimental Surgery, 3Department of Flow Cytometry, Institut Jules Bordet, Université Libre de Bruxelles; 4Interdisciplinary Research Institute (IRIBHM); Departments of 5Experimental Hematology and 6Pathology, 7Medical Oncology, Institut Jules Bordet, Brussels, Belgium; 8Computational Biology and Functional Genomics Laboratory, Center for Cancer Computational Biology, Dana-Farber Cancer Institute, Harvard School of Public Health, Boston, Massachusetts; and 9Département de formation et recherche, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland Institute Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. Electronic address: martine.piccart@bordet.be. 1BrEAST Data Center, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. Breast International Group Headquarters (BIG-aisbl), Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium; Université Libre de Bruxelles, Brussels, Belgium; Institut Jules Bordet, Boulevard de Waterloo, 125, 1000 Brussels, Belgium. . 5Institut Jules Bordet and l'Université Libre de Bruxelles (U.LB), Belgium. Institut Jules Bordet Université Libre de Bruxelles (U.L.B) Brussels Belgium 5Institut Jules Bordet and L’Université Libre de Bruxelles (U.L.B.), Brussels, Belgium; |
Incoming Links
Total number of triples: 327.